Well Done LLC’s Globus Medical GMED Stock Holding History

Well Done LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-82	Closed	-$4K	–	348
2018 Q4	$4K	Buy	+82	New	+$4.09K	﹤0.01%	592

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Well Done LLC's GMED Position: Q1 2019 in Review

Well Done LLC sold out of Globus Medical (GMED) in Q1 2019, closing a stake of 82 shares — an estimated $4K sold.

Well Done LLC first reported a position in GMED in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 269 funds tracked by Wall St. Rank hold GMED as of Q1 2019.

Well Done LLC reported no remaining Globus Medical position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 82 Globus Medical shares in Q1 2019, an estimated $4K.
Well Done LLC first reported a position in Globus Medical in Q4 2018 and held it in 1 quarter.
Well Done LLC's Globus Medical position peaked at $4K in Q4 2018.
269 funds tracked by Wall St. Rank held Globus Medical as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.